AIDS Cases Diagnosed in 1997 and 1998
By Sex, Race/Ethnicity, Age at Diagnosis, and Risk Exposure
Table 1: 1997
HIV/AIDS Surveillance Supplemental Report Vol. 5/No. 3
From U.S. Centers for Disease Control and Prevention
January 5, 2000
| Estimated Male Adult/Adolescent AIDS Cases Diagnosed in 1997 Adjusted for Reporting Delays and Risk Redistribution |
| |
Age at Diagnosis |
13-24 |
25-39 |
40-64 |
65+ |
| Exposure Category |
No. |
(%) |
No. |
(%) |
No. |
(%) |
No. |
(%) |
| White, Not Hispanic |
Men who have sex with men (MSM) |
178 |
66.4 |
5,584 |
73.8 |
4,199 |
72.6 |
137 |
72.5 |
| Injection drug use (IDU) |
33 |
12.3 |
888 |
11.7 |
860 |
14.9 |
10 |
5.3 |
| MSM and IDU |
15 |
5.6 |
667 |
8.8 |
334 |
5.8 |
5 |
2.6 |
| Hemophilia/coagulation disorder |
22 |
8.2 |
56 |
0.7 |
30 |
0.5 |
3 |
1.6 |
| Blood transfusion/components |
4 |
1.5 |
30 |
0.4 |
53 |
0.9 |
10 |
5.3 |
| Heterosexual contact |
15 |
5.6 |
329 |
4.3 |
290 |
5.0 |
21 |
11.1 |
| Other |
1 |
0.4 |
14 |
0.2 |
14 |
0.2 |
3 |
1.6 |
| Total |
268 |
|
7,568 |
|
5,780 |
|
189 |
|
| Black, Not Hispanic |
Men who have sex with men (MSM) |
298 |
64.2 |
3,939 |
48.9 |
2,148 |
29.8 |
105 |
34.8 |
| Injection drug use (IDU) |
65 |
14.0 |
2,230 |
27.7 |
3,413 |
47.4 |
102 |
33.8 |
| MSM and IDU |
16 |
3.4 |
557 |
6.9 |
442 |
6.1 |
8 |
2.6 |
| Hemophilia/coagulation disorder |
5 |
1.1 |
20 |
0.2 |
15 |
0.2 |
2 |
0.7 |
| Blood transfusion/components |
3 |
0.6 |
32 |
0.4 |
38 |
0.5 |
8 |
2.6 |
| Heterosexual contact |
71 |
15.3 |
1,254 |
15.6 |
1,130 |
15.7 |
76 |
25.2 |
| Other |
6 |
1.3 |
19 |
0.2 |
17 |
0.2 |
1 |
0.3 |
| Total |
464 |
|
8,051 |
|
7,203 |
|
302 |
|
| Hispanic |
Men who have sex with men (MSM) |
173 |
56.4 |
2,218 |
49.1 |
1,096 |
37.5 |
36 |
31.3 |
| Injection drug use (IDU) |
64 |
20.8 |
1,454 |
32.2 |
1,242 |
42.5 |
27 |
23.5 |
| MSM and IDU |
20 |
6.5 |
285 |
6.3 |
150 |
5.1 |
2 |
1.7 |
| Hemophilia/coagulation disorder |
5 |
1.6 |
13 |
0.3 |
5 |
0.2 |
0 |
· |
| Blood transfusion/components |
2 |
0.7 |
19 |
0.4 |
21 |
0.7 |
6 |
5.2 |
| Heterosexual contact |
39 |
12.7 |
512 |
11.3 |
402 |
13.8 |
42 |
36.5 |
| Other |
4 |
1.3 |
14 |
0.3 |
7 |
0.2 |
2 |
1.7 |
| Total |
307 |
|
4,515 |
|
2,923 |
|
115 |
|
| Asian/Pacific Islander |
Men who have sex with men (MSM) |
12 |
85.7 |
127 |
72.2 |
82 |
61.7 |
3 |
50.0 |
| Injection drug use (IDU) |
1 |
7.1 |
20 |
11.4 |
28 |
21.1 |
1 |
16.7 |
| MSM and IDU |
0 |
· |
5 |
2.8 |
4 |
3.0 |
0 |
· |
| Hemophilia/coagulation disorder |
1 |
7.1 |
1 |
0.6 |
0 |
· |
0 |
· |
| Blood transfusion/components |
0 |
· |
2 |
1.1 |
4 |
3.0 |
0 |
· |
| Heterosexual contact |
0 |
· |
20 |
11.4 |
14 |
10.5 |
2 |
33.3 |
| Other |
0 |
· |
1 |
0.6 |
1 |
0.8 |
0 |
· |
| Total |
14 |
|
176 |
|
133 |
|
6 |
|
| American Indian/Alaska Native |
Men who have sex with men (MSM) |
1 |
33.3 |
47 |
52.8 |
28 |
65.1 |
0 |
· |
| Injection drug use (IDU) |
1 |
33.3 |
22 |
24.7 |
8 |
18.6 |
0 |
· |
| MSM and IDU |
1 |
33.3 |
10 |
11.2 |
0 |
· |
0 |
· |
| Hemophilia/coagulation disorder |
0 |
· |
1 |
1.1 |
0 |
· |
0 |
· |
| Blood transfusion/components |
0 |
· |
0 |
· |
0 |
· |
0 |
· |
| Heterosexual contact |
0 |
· |
8 |
9.0 |
7 |
16.3 |
0 |
· |
| Other |
0 |
· |
1 |
1.1 |
0 |
· |
0 |
· |
| Total |
3 |
|
89 |
|
43 |
|
0 |
|
| Male Subtotal* |
|
1,057 |
|
20,455 |
|
16,133 |
|
612 |
|
| *Totals include cases with unknown or missing race/ethnicity data. |
| Estimated Female Adult/Adolescent AIDS Cases Diagnosed in 1997 Adjusted for Reporting Delays and Risk Redistribution |
| |
Age at Diagnosis |
13-24 |
25-39 |
40-64 |
65+ |
| Exposure Category |
No. |
(%) |
No. |
(%) |
No. |
(%) |
No. |
(%) |
| White, Not Hispanic |
Injection drug use (IDU) |
33 |
26.6 |
494 |
42.4 |
307 |
43.7 |
5 |
19.2 |
| Hemophilia/coagulation disorder |
1 |
0.8 |
3 |
0.3 |
4 |
0.6 |
1 |
3.8 |
| Blood transfusion/components |
3 |
2.4 |
18 |
1.5 |
16 |
2.3 |
2 |
7.7 |
| Heterosexual contact |
85 |
68.5 |
642 |
55.1 |
370 |
52.6 |
18 |
69.2 |
| Other |
2 |
1.6 |
9 |
0.8 |
6 |
0.9 |
0 |
· |
| Total |
124 |
|
1,166 |
|
703 |
|
26 |
|
| Black, Not Hispanic |
Injection drug use (IDU) |
101 |
19.7 |
1,468 |
36.8 |
1,178 |
46.4 |
24 |
21.4 |
| Hemophilia/coagulation disorder |
1 |
0.2 |
21 |
0.5 |
15 |
0.6 |
2 |
1.8 |
| Blood transfusion/components |
10 |
1.9 |
66 |
1.7 |
58 |
2.3 |
7 |
6.3 |
| Heterosexual contact |
393 |
76.6 |
2,421 |
60.6 |
1,276 |
50.3 |
77 |
68.8 |
| Other |
8 |
1.6 |
17 |
0.4 |
12 |
0.5 |
2 |
1.8 |
| Total |
513 |
|
3,993 |
|
2,539 |
|
112 |
|
| Hispanic |
Injection drug use (IDU) |
31 |
25.0 |
457 |
37.8 |
252 |
32.4 |
6 |
18.2 |
| Hemophilia/coagulation disorder |
0 |
· |
5 |
0.4 |
6 |
0.8 |
0 |
· |
| Blood transfusion/components |
4 |
3.2 |
16 |
1.3 |
7 |
0.9 |
1 |
3.0 |
| Heterosexual contact |
83 |
66.9 |
727 |
60.2 |
511 |
65.7 |
26 |
78.8 |
| Other |
6 |
4.8 |
3 |
0.2 |
2 |
0.3 |
0 |
· |
| Total |
124 |
|
1,208 |
|
778 |
|
33 |
|
| Asian/Pacific Islander |
Injection drug use (IDU) |
1 |
33.3 |
8 |
27.6 |
5 |
29.4 |
0 |
· |
| Hemophilia/coagulation disorder |
0 |
· |
1 |
3.4 |
0 |
· |
0 |
· |
| Blood transfusion/components |
0 |
· |
0 |
· |
2 |
11.8 |
0 |
· |
| Heterosexual contact |
1 |
33.3 |
20 |
69.0 |
10 |
58.8 |
0 |
· |
| Other |
1 |
33.3 |
0 |
· |
0 |
· |
0 |
· |
| Total |
3 |
|
29 |
|
17 |
|
0 |
|
| American Indian/Alaska Native |
Injection drug use (IDU) |
0 |
· |
11 |
55.0 |
2 |
18.2 |
0 |
· |
| Hemophilia/coagulation disorder |
0 |
· |
0 |
· |
1 |
9.1 |
0 |
· |
| Blood transfusion/components |
0 |
· |
0 |
· |
1 |
9.1 |
0 |
· |
| Heterosexual contact |
1 |
100 |
9 |
45.0 |
7 |
63.6 |
0 |
· |
| Other |
0 |
· |
0 |
· |
0 |
· |
0 |
· |
| Total |
1 |
|
20 |
|
11 |
|
0 |
|
| Female Subtotal* |
|
767 |
|
6,430 |
|
4,062 |
|
171 |
|
| 1997 Total* |
|
1,824 |
|
26,885 |
|
20,195 |
|
783 |
|
| *Totals include cases with unknown or missing race/ethnicity data. |
|
|
Advertisement
|
Email
Print-Friendly
Glossary
This article was provided by U.S. Centers for Disease Control and Prevention. 
